Fig. 1: Patient journey while receiving anticancer therapies. | Nature Reviews Nephrology

Fig. 1: Patient journey while receiving anticancer therapies.

From: The nephrotoxic effects of anti-cancer therapies: consensus report of the 34th Acute Disease Quality Initiative workgroup

Fig. 1

Prior to administration of nephrotoxic anticancer therapies, all patients should undergo a Kidney Health Assessment. The Kidney Health Assessment is a personalized evaluation of the kidney health of the patient and their potential risk of acute kidney disease (AKD) if exposed to the planned anticancer therapy. The Kidney Health Assessment is followed by a personalized Kidney Health Response, which is a risk mitigation and monitoring plan aimed at minimizing AKD risk, mitigating and/or managing AKD complications, avoiding further injuries, managing comorbid conditions impacted by AKD and facilitating rapid recovery.

Back to article page